Skip to main content

Table 5 Intersection of p53 probes between early and advanced cancers.

From: Expression signatures of TP53 mutations in serous ovarian cancers

 

Mutant v Wild Type

Missense v Wild Type

Stage

# probes*

Common

Top 100**

1000**

# probes

Common

Top 100

1000

Early

42

   

28

   
  

1

2

41

 

0

2

46

Advanced

68

   

17

   
  1. * Number of probes used for prediction modeling from Table 2
  2. ** The intersection of the top 100/1000 probe sets from early and advanced cancers
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us